| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6194286 | Urologic Oncology: Seminars and Original Investigations | 2014 | 8 Pages |
Abstract
The consistent outcomes in our post-RFA imaging and clinical surveillance allow us to offer image-guided ablation to patients with T1a RCCa as a valid treatment option offering long-term cancer-free survival. Impedance-based RFA in a carefully selected patient population with T1a RCCa is a reliable treatment option, with disease-free survival rates that are comparable to partial nephrectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Andrew R. M.D., F.S.I.R., Benjamin J. B.S., John D. M.B., F.A.C.S.,